ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

$411M Chip Dump: NVDA Director Cashes Out

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

An NVIDIA board member filed a massive stock sale earlier this month. Independent Director Mark Stevens disclosed $411 million in NVIDIA shares sold between August 31 and September 2, covering nearly 1.85 million shares.

The filings hit SEC records on September 2. Stevens sold across multiple transactions over three days, with single-day proceeds topping $265 million on September 2 alone. There is no confirmation these sales were made under a pre-arranged 10b5-1 plan, making the discretionary nature of the trades worth watching closely.

NVIDIA shares have been a topic of heavy short-seller attention this week. ORTEX data shows bears piling into EV and chip names simultaneously, adding context to why the director's exit stands out.

Across the Atlantic, Evolution AB tells a contrasting story. Billionaire Kenneth Dart, a major shareholder, filed purchases of over $716 million in Evolution stock between July and August 2026, disclosed on August 26. Dart has now accumulated more than $3.9 billion in Evolution shares across multiple filing rounds since 2024 — a rare display of sustained conviction from a single large holder.

Ather Energy saw investment firm Caladium sell $204 million in shares in late August, filed September 1 — a notable exit from the Indian EV maker.

Insider activity this week signals mixed sentiment. Selling dominates at chip names, while one European gaming giant continues attracting heavyweight buying.

Stocks in this article

How this article was generated

Generated
13 Sept 2026, 04:14
Prompt version
v1.0
Data sources
Institutional positioning

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.